• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有抗 HCV/HIV 活性和增强特异性的肽的合理设计。

Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.

机构信息

Key Laboratory for Molecular Enzymology and Engineering of the Ministry of Education, Jilin University, Changchun, Jilin, China.

出版信息

Chem Biol Drug Des. 2011 Nov;78(5):835-43. doi: 10.1111/j.1747-0285.2011.01201.x. Epub 2011 Sep 26.

DOI:10.1111/j.1747-0285.2011.01201.x
PMID:21801309
Abstract

Lack of vaccines for HCV and HIV makes the antiviral drug development urgently needed. The recently identified HCV NS5A-derived virucidal peptide (C5A) demonstrated a wide spectrum of activities against viruses. In this study, the C5A sequence SWLRDIWDWICEVLSDFK was utilized as the framework to study the effect of the modulation of peptide helicity and hydrophobicity on its anti-HCV and anti-HIV activities. Peptide helicity and hydrophobicity were altered by substitutions of varying amino acids on the non-polar face of C5A. Peptide hydrophobicity has been proved to play a crucial role in peptide anti-HCV or anti-HIV activities. Peptide helicity was relatively independent with antiviral activity. However, peptide analogs with dimerized structure in an aqueous medium while maintaining the ability to be induced into a more helical structure in a hydrophobic environment may tend to show comparable or improved antiviral activity and specificity to C5A. By modulating peptide helicity and hydrophobicity, we improved the specificity of C5A against HCV and HIV by 23- and 69-fold, respectively, in terms of the ratio of hemolytic activity to antiviral activity. We demonstrated that obtained by de novo design approach, peptide I6L/I10L/V13L may be a promising candidate as a new anti-HCV and anti-HIV therapeutic.

摘要

缺乏 HCV 和 HIV 的疫苗使得抗病毒药物的开发变得迫切需要。最近发现的 HCV NS5A 衍生的病毒杀伤肽 (C5A) 对多种病毒表现出广泛的活性。在这项研究中,利用 C5A 序列 SWLRDIWDWICEVLSDFK 作为框架,研究了调节肽螺旋性和疏水性对其抗 HCV 和抗 HIV 活性的影响。通过改变 C5A 非极性面上的不同氨基酸来改变肽的螺旋性和疏水性。已经证明肽疏水性在肽抗 HCV 或抗 HIV 活性中起着至关重要的作用。肽螺旋性与抗病毒活性相对独立。然而,在水介质中具有二聚化结构的肽类似物同时保持在疏水环境中诱导形成更螺旋结构的能力,可能倾向于表现出与 C5A 相当或改善的抗病毒活性和特异性。通过调节肽的螺旋性和疏水性,我们将 C5A 对 HCV 和 HIV 的特异性分别提高了 23 倍和 69 倍,这是溶血活性与抗病毒活性之比。我们证明,通过从头设计方法获得的肽 I6L/I10L/V13L 可能是一种有前途的抗 HCV 和抗 HIV 治疗候选药物。

相似文献

1
Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.具有抗 HCV/HIV 活性和增强特异性的肽的合理设计。
Chem Biol Drug Des. 2011 Nov;78(5):835-43. doi: 10.1111/j.1747-0285.2011.01201.x. Epub 2011 Sep 26.
2
Role of helicity on the anticancer mechanism of action of cationic-helical peptides.螺旋度在阳离子螺旋肽抗癌作用机制中的作用
Int J Mol Sci. 2012;13(6):6849-6862. doi: 10.3390/ijms13066849. Epub 2012 Jun 5.
3
Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.从庚型肝炎病毒 NS5A 筛选并合理设计丙型肝炎病毒进入抑制剂肽。
J Virol. 2013 Feb;87(3):1649-57. doi: 10.1128/JVI.02201-12. Epub 2012 Nov 21.
4
Antiviral activity of virocidal peptide derived from NS5A against two different HCV genotypes: an in vitro study.源自NS5A的杀病毒肽对两种不同丙型肝炎病毒基因型的抗病毒活性:一项体外研究
J Immunoassay Immunochem. 2015;36(1):63-79. doi: 10.1080/15321819.2014.896264.
5
Role of helicity of α-helical antimicrobial peptides to improve specificity.α-螺旋抗菌肽的螺旋性在提高特异性方面的作用。
Protein Cell. 2014;5(8):631-42. doi: 10.1007/s13238-014-0061-0. Epub 2014 May 9.
6
Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.具有增强活性、特异性/治疗指数的α-螺旋抗菌肽的合理设计。
J Biol Chem. 2005 Apr 1;280(13):12316-29. doi: 10.1074/jbc.M413406200. Epub 2005 Jan 27.
7
Antiviral peptide nanocomplexes as a potential therapeutic modality for HIV/HCV co-infection.抗病毒肽纳米复合物作为一种治疗 HIV/HCV 合并感染的潜在治疗方式。
Biomaterials. 2013 May;34(15):3846-57. doi: 10.1016/j.biomaterials.2013.01.026. Epub 2013 Feb 10.
8
Effects and mechanisms of the secondary structure on the antimicrobial activity and specificity of antimicrobial peptides.二级结构对抗菌肽抗菌活性及特异性的影响与机制
J Pept Sci. 2015 Jul;21(7):561-8. doi: 10.1002/psc.2767. Epub 2015 Mar 30.
9
Mechanism of an amphipathic alpha-helical peptide's antiviral activity involves size-dependent virus particle lysis.两亲性 α-螺旋肽的抗病毒活性机制涉及尺寸依赖性病毒粒子裂解。
ACS Chem Biol. 2009 Dec 18;4(12):1061-7. doi: 10.1021/cb900149b.
10
Structure-activity relationships of anti-HIV-1 peptides with disulfide linkage between D- and L-cysteine at positions i and i+3, respectively, derived from HIV-1 gp41 C-peptide.源自HIV-1 gp41 C肽的、在第i位和i + 3位分别具有D-半胱氨酸和L-半胱氨酸之间二硫键的抗HIV-1肽的构效关系。
Exp Mol Med. 2006 Feb 28;38(1):18-26. doi: 10.1038/emm.2006.3.

引用本文的文献

1
The Role of Peptides in Combatting HIV Infection: Applications and Insights.肽在抗击 HIV 感染中的作用:应用与见解。
Molecules. 2024 Oct 19;29(20):4951. doi: 10.3390/molecules29204951.
2
Proteochemometric Method for pIC50 Prediction of Flaviviridae.基于定量构效关系的黄病毒 pIC50 预测方法
Biomed Res Int. 2022 Sep 15;2022:7901791. doi: 10.1155/2022/7901791. eCollection 2022.
3
Hybridization with Insect Cecropin A (1-8) Improve the Stability and Selectivity of Naturally Occurring Peptides.与昆虫抗菌肽 Cecropin A(1-8)杂交可提高天然存在的肽的稳定性和选择性。
Int J Mol Sci. 2020 Feb 21;21(4):1470. doi: 10.3390/ijms21041470.
4
Infectivity inhibition by overlapping synthetic peptides derived from the gH/gL heterodimer of herpes simplex virus type 1.源自单纯疱疹病毒1型gH/gL异二聚体的重叠合成肽对感染性的抑制作用
J Pept Sci. 2017 Apr;23(4):311-319. doi: 10.1002/psc.2979. Epub 2017 Feb 14.
5
A Novel Human Radixin Peptide Inhibits Hepatitis C Virus Infection at the Level of Cell Entry.一种新型人根蛋白肽在细胞进入水平抑制丙型肝炎病毒感染。
Int J Pept Res Ther. 2014 Sep;20(3):269-276. doi: 10.1007/s10989-013-9390-8.
6
Peptide entry inhibitors of enveloped viruses: the importance of interfacial hydrophobicity.包膜病毒的肽类进入抑制剂:界面疏水性的重要性。
Biochim Biophys Acta. 2014 Sep;1838(9):2180-97. doi: 10.1016/j.bbamem.2014.04.015. Epub 2014 Apr 26.
7
Model membrane platforms for biomedicine: case study on antiviral drug development.用于生物医药的模型膜平台:以抗病毒药物开发为例。
Biointerphases. 2012 Dec;7(1-4):18. doi: 10.1007/s13758-011-0018-2. Epub 2012 Feb 11.